SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Medical - Drugs >

Abbott Laboratories (ABT)

ABT RSS Feed
Add ABT Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 3/24/2017 10:19:39 AM - Followers: 30 - Board type: Free - Posts Today: 0

Additional discussion of ABT, its competitors, and the
industries in which it operates may be found on the board,
Natural Resources /The Global Demographic Tailwind.


ABT Investor Relations

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ABT
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ABT News: Statement of Changes in Beneficial Ownership (4) 03/24/2017 05:07:50 PM
ABT News: Current Report Filing (8-k) 03/22/2017 02:47:13 PM
ABT News: Abbott Hosts Conference Call for First-Quarter Earnings 03/22/2017 09:00:00 AM
ABT News: Notice of Effectiveness (effect) 03/21/2017 06:01:32 AM
ABT News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 03/20/2017 04:57:02 PM
PostSubject
#342  Sticky Note ABT formally seeks to kill ALR acquisition: #msg-127071124. DewDiligence 12/07/16 11:28:14 AM
#359   ABT pares MYL stake: #msg-129833882. DewDiligence 03/24/17 10:19:38 AM
#358   Freestyle Libre glucose monitor yields mountains of useful DewDiligence 03/18/17 12:52:21 PM
#357   Freestyle Libre continuous-glucose-monitoring system shows real-world results consistent DewDiligence 02/15/17 09:57:43 AM
#356   ABT SVP bought $500K of stock on 1/31/17: DewDiligence 02/12/17 05:40:25 PM
#355   ABT 4Q16 results and 2017 guidance: DewDiligence 01/25/17 08:44:17 AM
#354   ACCURATE Study Confirms Superiority Of Abbott Laboratories (NYSE:ABT) trendmkr 01/18/17 11:26:34 AM
#353   ABT closes STJ merger: DewDiligence 01/04/17 05:24:55 PM
#352   ABT-STJ merger will close on 1/4/17: DewDiligence 12/30/16 01:38:43 PM
#351   I expect at least a modest bounce if DewDiligence 12/28/16 02:38:38 PM
#350   I wonder how the stock will respond if inversor86 12/28/16 02:33:42 PM
#349   FTC OKs ABT-STJ merger—subject to two divestitures: DewDiligence 12/27/16 06:44:09 PM
#348   A second EVP bought $600K of stock yesterday: DewDiligence 12/21/16 02:38:28 PM
#347   You are on top of everything Dew. inversor86 12/20/16 12:08:19 PM
#346   Right—I noted the insider purchase on two other DewDiligence 12/20/16 12:03:57 PM
#345   The Executive VP of Medical Devices bought 12,000 inversor86 12/20/16 11:59:59 AM
#343   ABT raises dividend for 45th(!) consecutive year: DewDiligence 12/09/16 10:54:02 AM
#342   ABT formally seeks to kill ALR acquisition: #msg-127071124. DewDiligence 12/07/16 11:28:14 AM
#341   The debt offering is routine, as far as DewDiligence 11/24/16 08:54:26 AM
#340   Perhaps also some dissatisfaction with their new debt offering. inversor86 11/24/16 01:03:20 AM
#339   GE and AMAVF seem to have done better north40000 11/22/16 04:08:16 PM
#338   http://seekingalpha.com/news/3226466-device-makers-feel-medtronics-pain Investors' sour mood wit inversor86 11/22/16 03:43:09 PM
#337   Perhaps, some mutual implant problems? But the 2 north40000 11/22/16 03:11:53 PM
#336   Looks like it's related to MDT, as 'inversor86' said. DewDiligence 11/22/16 02:55:16 PM
#335   Strong dollar? Advanced as reason by some, for north40000 11/22/16 02:39:01 PM
#334   Actually, ABT and MDT don't have much overlap, DewDiligence 11/22/16 01:22:17 PM
#333   Supposedly ABT dropped because MDT had bad earnings. inversor86 11/22/16 01:01:43 PM
#332   I don't have any explanation. DewDiligence 11/22/16 11:52:42 AM
#331   I'm surprised by the downtrade today. I inversor86 11/22/16 11:35:22 AM
#330   Most likely scenario, IMO, is that ABT and DewDiligence 11/21/16 08:50:06 AM
#329   Do you think the end result of the inversor86 11/21/16 01:29:24 AM
#328   ABT’s CEO bought another $15.2M of stock last week: DewDiligence 11/14/16 11:30:14 AM
#327   Small insider purchase: DewDiligence 11/02/16 06:50:40 PM
#326   Those P/E ratios are based on backward-looking GAAP DewDiligence 11/02/16 07:59:14 AM
#325   Do you know why ABT shows as trading inversor86 11/02/16 07:45:03 AM
#324   ABT reports 3Q16 results—narrows EPS guidance range: DewDiligence 10/19/16 08:32:14 AM
#323   Abbott's fundamental valuation analysis show shares are ~15% ValueInvestor15 10/18/16 05:36:50 PM
#322   It’s official—ABT sells ophthalmology unit to JNJ for DewDiligence 09/16/16 03:28:27 PM
#321   WSJ reporting that ABT is selling its ophthalmology DewDiligence 09/16/16 02:12:23 PM
#320   ALR sues ABT to compel consummation of merger: DewDiligence 08/26/16 11:08:36 AM
#319   Muddy Waters says STJ devices at-risk from cyberhacking: #msg-124765706. DewDiligence 08/25/16 11:51:05 AM
#318   ABT’s CEO buys $46M of stock: #msg-124155254. DewDiligence 07/27/16 04:44:51 PM
#317   ABT’s 2Q16 sales in emerging markets—excluding Venezuela—grew 5% DewDiligence 07/20/16 11:16:37 AM
#316   2016 non-GAAP EPS guidance is unchanged at $2.14-2.24. DewDiligence 07/20/16 11:12:45 AM
#315   ABT +2% on solid 2Q16 results—sales in constant DewDiligence 07/20/16 10:07:24 AM
#314   FDA approves ABT’s bioabsorbable coronary stent: DewDiligence 07/05/16 11:16:31 AM
#313   Abbott Laboratories (NYSE:ABT) Releases Positive Data Regarding Tecnis venturecapp 05/09/16 01:57:46 PM
#312   ABT acquires STJ for $30.7B in cash and stock: DewDiligence 04/28/16 11:55:06 AM
#311   ABT raised 2016 guidance based on a solid DewDiligence 04/20/16 02:32:58 PM
#310   Reading between the lines on ABT’s 1Q16 CC, DewDiligence 04/20/16 09:20:50 AM
#309   FDA panel endorses ABT’s ABSORB stent by 9-0 vote: DewDiligence 03/15/16 05:27:19 PM
PostSubject